»Æ¹Ï¶ÌÊÓÆµ

David Hess

EVP, Med Affairs & Dean, MCG

David Hess

EVP, Med Affairs & Dean, MCG

Professor

Academic Appointment(s)

Medical College of Georgia
Department of Neurology

Medical College of Georgia
Department of Medicine

Administration
Department of The »Æ¹Ï¶ÌÊÓÆµ School

Other Duties

Presidential Distinguished Chair, Neurology

Bio

David C. Hess MD, a stroke specialist, federally funded investigator, honored educator and biotech entrepreneur, is the 27th Dean of the Medical College of Georgia and Executive Vice President for Medical Affairs and Integration at »Æ¹Ï¶ÌÊÓÆµ.
Dr. Hess also continues to serve as Presidential Distinguished Chair and as a Professor in the MCG Department of Neurology. He is a graduate of the Johns Hopkins University and the University of Maryland School of Medicine. He is triple board certified in Internal Medicine, Neurology, and Vascular Neurology. He completed his Neurology residency and Vascular Neurology/Stroke fellowship at MCG and AU Health System.

  • DHESS@augusta.edu
  • (706) 721-2231
  • AA 1006

Education

  • MD, Medicine University of Maryland - Balti, 1983

  • BA, Humanities/Humanistic Studies Johns Hopkins University, 1979

Certifications

  • PHY State of GA, 1986

  • ABPNVN ABPN, 2008

  • ABPN ABPN, 1990

  • ABIM ABIM, 1986

Awards & Honors

  • Exemplary Teaching Award for Medical Student Education MCG, 2025

  • Exemplary Teaching Award for Medical Student Education MCG, 2024

  • Exemplary Teaching Award for Medical Student Education MCG, 2023

  • Regents' Entrepreneur University System of Georgia, 2023

  • Exemplary Teaching Award for Medical Student Education MCG, 2022

Courses Taught Most Recent Academic Year

  • RNEU 5000

    Neurology

Teaching Interests

Dr. Hess lectures in the MCG Brain and Behavior Module focusing in the area of remote ischemic limb conditioning (RIC) as a treatment for acute ischemic stroke and vascular cognitive impairment.

Scholarship

Selected Recent Publications

  • Altered endocannabinoid metabolism compromises the brain-CSF barrier and exacerbates chronic deficits after traumatic brain injury in mice., 2023
    Journal Article, Academic Journal
  • The time dimension to stroke: Circadian effects on stroke outcomes and mechanisms., 2023
    Journal Article, Academic Journal
  • Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in China., 2022
    Journal Article, Academic Journal
  • Recycled Translation: Repurposing Drugs for Stroke., 2022
    Journal Article, Academic Journal
  • Neuropsychiatric sequelae of long COVID-19: Pilot results from the COVID-19 neurological and molecular prospective cohort study in Georgia, USA., 2022
    Journal Article, Academic Journal

Research Interests

Dr. Hess has a major interest in the area of remote ischemic limb conditioning (RIC) as a treatment for acute ischemic stroke and vascular cognitive impairment. Dr. Hess has over 250 peer-reviewed publications and has been involved in basic, pre-clinical and clinical stroke research. He currently is the Principal Investigator on two National Institutes of Health grants.

Professional Service

  • 2015 - Present

    Role: Editorial Review Board Member
  • 2015 - Present

    Role: Reviewer, Ad Hoc Reviewer